Literature DB >> 3731419

Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis.

M Grover-McKay, H R Schelbert, M Schwaiger, H Sochor, P M Guzy, J Krivokapich, J S Child, M E Phelps.   

Abstract

We investigated myocardial 11C-palmitate clearance kinetics at a resting heart rate (control) and during pacing using positron-emission tomography in 10 patients with significant coronary artery stenosis (greater than 70%) and evidence of exercise-induced ischemia. Serial 11C-palmitate images acquired at control and during pacing revealed biexponential myocardial 11C clearance both in myocardium supplied by a stenotic coronary artery (myocardium "at risk") and in myocardium supplied by a normal coronary artery (normal myocardium). At control, the average rate of myocardial 11C clearance from the early rapid curve component (the clearance half-time) was similar in normal myocardium and in that at risk (22.2 +/- 5.2 vs 21.0 +/- 5.4 min, NS), as was the amount of myocardial 11C activity at the end of the early rapid phase (residual fraction 56.3 +/- 7.2% vs 54.7 +/- 7.3%, NS). Thus, myocardial clearance was homogeneous at control, suggesting a similar rate and amount of 11C-palmitate oxidation in normal myocardium and in that at risk. Pacing shortened clearance half-times and decreased residual fraction in both normal myocardium and that at risk compared with control. However, clearance half-times were 17% longer and residual fractions 14% higher in myocardium at risk compared with normal myocardium (p less than .005 and p less than .01, respectively). Therefore, during pacing myocardial 11C clearance became heterogeneous, suggesting impaired 11C-palmitate oxidation in myocardium at risk compared with normal myocardium. Increased substrate utilization in response to increased workload can be thought of as a measure of metabolic reserve. Our data suggest metabolic reserve for free fatty acid oxidation is impaired in myocardium supplied by a significantly stenosed coronary artery and that this impairment can be detected by analysis of myocardial 11C-palmitate clearance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731419     DOI: 10.1161/01.cir.74.2.281

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

2.  Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.

Authors:  N Tamaki; M Kawamoto; N Takahashi; Y Yonekura; Y Magata; R Nohara; H Kambara; C Kawai; J Konishi
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

Review 3.  Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease.

Authors:  P G Camici
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

4.  Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; E Tadamura; K Okuda; S Ono; R Nohara
Journal:  Eur J Nucl Med       Date:  1993-03

Review 5.  Clinical applications of assessments of myocardial substrate utilization with positron emission tomography.

Authors:  S R Bergmann
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

Review 6.  Positron emission tomography. Diagnostic and therapeutic implications in human myocardial ischemia.

Authors:  H R Schelbert
Journal:  Int J Card Imaging       Date:  1987

Review 7.  Assessment of myocardial fatty acid metabolism with 1-11C-palmitate.

Authors:  E M Geltman
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

8.  Cardiac ischemia. Part I--Metabolic and physiologic responses.

Authors:  G A Langer; J N Weiss; H R Schelbert
Journal:  West J Med       Date:  1987-06

Review 9.  Cardiac nuclear medicine: positron emission tomography in clinical medicine.

Authors:  A Storch-Becker; K P Kaiser; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1988

10.  Clinical usefulness of iodine 123-labeled fatty acid imaging in patients with acute myocardial infarction.

Authors:  H Naruse; T Arii; T Kondo; M Morita; M Ohyanagi; T Iwasaki; M Fukuchi
Journal:  J Nucl Cardiol       Date:  1998 May-Jun       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.